Getting physical to fix pharma

Nature Chemistry
P R ConnellyMark A Murcko


Powerful technologies allow the synthesis and testing of large numbers of new compounds, but the failure rate of pharmaceutical R&D remains very high. Greater understanding of the fundamental physical chemical behaviour of molecules could be the key to greatly enhancing the success rate of drug discovery.


Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J Wyman
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·P R ConnellyJ A Thomson
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·V A ParsegianD C Rau
Jul 28, 2001·Pharmaceutical Research·J BauerJ Morris
Nov 3, 2004·Nature Reviews. Drug Discovery·Colin R GardnerOrn Almarsson
Apr 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Omid C FarokhzadRobert Langer
Jul 22, 2006·The Journal of Pharmacology and Experimental Therapeutics·Terry KenakinChristian Watson
Jun 22, 2007·Chemical Biology & Drug Design·Virginie LafontErnesto Freire
Jun 28, 2007·Expert Opinion on Investigational Drugs·Felix KratzAndré Warnecke
Jul 7, 2007·Science·Andrea M ArmaniKerry J Vahala
Sep 29, 2007·Angewandte Chemie·Gautam R Desiraju
Dec 25, 2007·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Hendrik HölscherUdo D Schwarz
Jun 25, 2008·Annual Review of Biophysics·Huan-Xiang ZhouAllen P Minton
Oct 29, 2008·Molecular Pharmaceutics·J F Willart, M Descamps
Feb 11, 2009·Journal of Medicinal Chemistry·Michele H Potashman, Mark E Duggan
Mar 12, 2009·Current Medicinal Chemistry·Jie Lu, Sohrab Rohani
Aug 5, 2009·Protein Science : a Publication of the Protein Society·Jerry M Thomas, Patrick S Daugherty
Sep 15, 2009·Structure·Mee Whi KimIlya Bezprozvanny
Oct 1, 2009·Lab on a Chip·Sudeep MandalDavid Erickson
Oct 21, 2009·Nature Chemical Biology·Lila M Gierasch, Anne Gershenson
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Benjamin C TangJustin Hanes
Dec 25, 2009·Nature·Wenjun ZhouPasi A Jänne
Jan 19, 2010·Nature Nanotechnology·Rohan FernandesWilliam E Bentley
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Mar 2, 2010·Nature Methods·Simon EbbinghausMartin Gruebele
Mar 18, 2010·Journal of Pharmaceutical Innovation·Dan E DobryRon A Beyerinck
Aug 19, 2010·Lab on a Chip·George Whitesides
Feb 4, 2011·Angewandte Chemie·Wendelin J Stark
Feb 26, 2011·Current Opinion in Structural Biology·John D ChoderaVijay S Pande


Dec 21, 2011·Journal of Computer-aided Molecular Design·David W Borhani, David E Shaw
Sep 20, 2012·ISRN Dermatology·Saravanakumar KandasamyKathiresan Kandasamy
Jul 18, 2016·Drug Discovery Today·Martin K BaylissAnthony J Taylor
Jun 12, 2013·Journal of the American Chemical Society·Gautam R Desiraju
Mar 8, 2020·Nature Communications·Peter Ouma OkeyoAnja Boisen
May 19, 2019·Scientific Reports·Peter Ouma OkeyoJukka Rantanen

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Surgical Neurology International
Ronald Pawl
Heart Views : the Official Journal of the Gulf Heart Association
Austin Flint
© 2021 Meta ULC. All rights reserved